Brandon earned his PhD in Cell and Molecular Biology from the University of Texas Southwestern Medical Center in the lab of Dr. Steven McKnight. He then joined his first exciting startup biotech company, Joyant Pharmaceuticals. At Joyant, Brandon worked on two oncology programs, including the identification of the mechanism of action and a key biomarker for clinical utility. He then worked at Reata Pharmaceuticals for the next 8 years on multiple rare orphan diseases to support the generation of 5 INDs and 7 clinical trials. In his free time, Brandon enjoys spending time with his family, training and competing in endurance events (triathlons, marathons, etc) and spending time in the outdoors.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.